Dhiraj Tripathi

Summary

Affiliation: University of Edinburgh
Country: UK

Publications

  1. pmc Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding
    D Tripathi
    Liver Unit, The Royal Infirmary, Edinburgh, UK
    Gut 53:431-7. 2004
  2. ncbi request reprint Review article: a drug therapy for the prevention of variceal haemorrhage
    D Tripathi
    Liver Unit, Department of Medicine, Royal Infirmary, Edinburgh, UK
    Aliment Pharmacol Ther 15:291-310. 2001
  3. ncbi request reprint Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension
    D Tripathi
    Liver Unit, Department of Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK
    Aliment Pharmacol Ther 16:373-80. 2002
  4. ncbi request reprint Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation
    Dhiraj Tripathi
    Department of Medicine, The Royal Infirmary, Edinburgh, Scotland
    Eur J Gastroenterol Hepatol 14:827-32. 2002
  5. ncbi request reprint Ten years' follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre
    Dhiraj Tripathi
    Liver Unit, The Royal Infirmary, Edinburgh, UK
    Eur J Gastroenterol Hepatol 16:9-18. 2004
  6. ncbi request reprint Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents
    Dhiraj Tripathi
    Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, Scotland, UK
    Eur J Gastroenterol Hepatol 18:225-32. 2006
  7. doi request reprint Tipsitis: incidence and outcome-a single centre experience
    Narendra Kochar
    Departments of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK
    Eur J Gastroenterol Hepatol 22:729-35. 2010
  8. doi request reprint Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed
    Dhiraj Tripathi
    Royal Infirmary, Edinburgh, United Kingdom
    Hepatology 50:825-33. 2009
  9. ncbi request reprint Transjugular intrahepatic portosystemic stent-shunt in the management of gastric and ectopic varices
    Dhiraj Tripathi
    Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK
    Eur J Gastroenterol Hepatol 18:1155-60. 2006
  10. ncbi request reprint Impact of transjugular intrahepatic portosystemic stent-shunt for secondary prophylaxis of oesophageal variceal haemorrhage: a single-centre study over an 11-year period
    Rajiv Jalan
    Liver Unit, Royal Infirmary Edinburg, UK
    Eur J Gastroenterol Hepatol 14:615-26. 2002

Detail Information

Publications25

  1. pmc Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding
    D Tripathi
    Liver Unit, The Royal Infirmary, Edinburgh, UK
    Gut 53:431-7. 2004
    ....
  2. ncbi request reprint Review article: a drug therapy for the prevention of variceal haemorrhage
    D Tripathi
    Liver Unit, Department of Medicine, Royal Infirmary, Edinburgh, UK
    Aliment Pharmacol Ther 15:291-310. 2001
    ..Correlations between haemodynamic and clinical parameters are discussed. Despite the recent increase in the use of alternative endoscopic therapies, an effective and well tolerated drug remains a clinically important research goal...
  3. ncbi request reprint Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension
    D Tripathi
    Liver Unit, Department of Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK
    Aliment Pharmacol Ther 16:373-80. 2002
    ..Carvedilol is a non-selective vasodilating beta-blocker with weak alpha1 receptor antagonism. Recent studies have demonstrated its potential as a portal hypotensive agent...
  4. ncbi request reprint Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation
    Dhiraj Tripathi
    Department of Medicine, The Royal Infirmary, Edinburgh, Scotland
    Eur J Gastroenterol Hepatol 14:827-32. 2002
    ....
  5. ncbi request reprint Ten years' follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre
    Dhiraj Tripathi
    Liver Unit, The Royal Infirmary, Edinburgh, UK
    Eur J Gastroenterol Hepatol 16:9-18. 2004
    ..Transjugular intrahepatic portosystemic stent-shunt (TIPSS) is increasingly used for the management of portal hypertension. We report on 10 years' experience at a single centre...
  6. ncbi request reprint Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents
    Dhiraj Tripathi
    Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, Scotland, UK
    Eur J Gastroenterol Hepatol 18:225-32. 2006
    ..Newer covered stents appear to have improved patency. This large study aimed to assess the shunt function and clinical efficacy of polytetrafluoroethylene-covered stents in a single centre...
  7. doi request reprint Tipsitis: incidence and outcome-a single centre experience
    Narendra Kochar
    Departments of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK
    Eur J Gastroenterol Hepatol 22:729-35. 2010
    ..Infection of transjugular intrahepatic portosystemic stent shunt (TIPSS) called 'Tipsitis' has been reported but appears unusual. We report here our experience of patients who were diagnosed to have Tipsitis at our centre...
  8. doi request reprint Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed
    Dhiraj Tripathi
    Royal Infirmary, Edinburgh, United Kingdom
    Hepatology 50:825-33. 2009
    ..71), and bleeding-related mortality (3% versus 1%, P = 0.26). Six patients in the VBL group bled as a result of banding ulcers. Per-protocol analysis revealed no significant differences in the outcomes...
  9. ncbi request reprint Transjugular intrahepatic portosystemic stent-shunt in the management of gastric and ectopic varices
    Dhiraj Tripathi
    Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK
    Eur J Gastroenterol Hepatol 18:1155-60. 2006
    ..Its use may be limited by availability or lack of technical expertise, and caution is required in patients with large oesophageal varices...
  10. ncbi request reprint Impact of transjugular intrahepatic portosystemic stent-shunt for secondary prophylaxis of oesophageal variceal haemorrhage: a single-centre study over an 11-year period
    Rajiv Jalan
    Liver Unit, Royal Infirmary Edinburg, UK
    Eur J Gastroenterol Hepatol 14:615-26. 2002
    ....
  11. doi request reprint A case-control study of transjugular intrahepatic portosystemic stent shunts for patients admitted to intensive care following variceal bleeding
    Chris Corbett
    Liver Unit, Queen Elizabeth Hospital, Birmingham, Birmingham, UK
    Eur J Gastroenterol Hepatol 25:344-51. 2013
    ..We aim to assess the outcomes following the insertion of covered TIPSS in a real-life intensive care setting...
  12. ncbi request reprint Chronic administration of losartan, an angiotensin II receptor antagonist, is not effective in reducing portal pressure in patients with preascitic cirrhosis
    Dhiraj Tripathi
    Liver Unit, Department of Medicine, Royal Infirmary, Edinburgh, UK
    Am J Gastroenterol 99:390-4. 2004
    ..We aimed to study both the systemic and portal hemodynamics, and tolerability after chronic administration of losartan, an ANG II receptor antagonist...
  13. doi request reprint Overview of the methods and therapies for the primary prevention of variceal bleeding
    Dhiraj Tripathi
    Liver Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham B152TH, UK
    Expert Rev Gastroenterol Hepatol 4:399-407. 2010
    ..Further studies are necessary before universal recommendation. There is no role for drug therapy in patients without varices, and the use of beta-blockers for patients with small varices is controversial...
  14. doi request reprint The role of carvedilol in the management of portal hypertension
    Dhiraj Tripathi
    Liver Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK
    Eur J Gastroenterol Hepatol 22:905-11. 2010
    ..The efficacy in primary prevention of variceal bleeding suggests that carvedilol has a role in the management of clinically significant portal hypertension...
  15. ncbi request reprint Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments
    Dhiraj Tripathi
    Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK
    Eur J Gastroenterol Hepatol 18:1127-33. 2006
    ..Despite the lack of controlled studies, covered stents are now widely used and have the potential to drastically reduce shunt insufficiency, the need for long-term shunt surveillance and even hepatic encephalopathy...
  16. doi request reprint Embolization of bleeding stomal varices by direct percutaneous approach
    Ramakrishnan Arulraj
    Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
    Cardiovasc Intervent Radiol 34:S210-3. 2011
    ..We consider percutaneous embolization to be an effective way of treating acute stomal bleeding in decompensated patients while awaiting decisions regarding shunt procedures or liver transplantation...
  17. ncbi request reprint Variceal band ligation versus beta-blockers for primary prevention of variceal bleeding: a meta-analysis
    Dhiraj Tripathi
    Department of Hepatology, Royal Infirmary of Edinburgh, Wellcome Trust Clinical Research Facility, Western General Hospital, Edinburgh, UK
    Eur J Gastroenterol Hepatol 19:835-45. 2007
    ..We performed an updated meta-analysis of nine randomized controlled trials published as full papers, comparing VBL with BB for primary prevention...
  18. ncbi request reprint Endoscopic use of human thrombin in bleeding gastric varices
    Wei Lyn Yang
    Centre for Liver and Digestive Disorders, Department of Medicine, Royal Infirmary of Edinburgh, United Kingdom
    Am J Gastroenterol 97:1381-5. 2002
    ..The management of gastric variceal hemorrhage remains a clinical challenge. Bovine thrombin has been reported to be effective in two small series. We report our experience with human thrombin in the treatment of bleeding gastric varices...
  19. pmc Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition
    Roland H Stimson
    Endocrinology Unit, Centre for Cardiovascular Science, Queen s Medical Research Institute, University of Edinburgh, Edinburgh, Scotland, UK
    Diabetes 60:720-5. 2011
    ..To examine this, we quantified in vivo whole-body, splanchnic, and hepatic 11β-HSD1 activity in obese type 2 diabetic subjects...
  20. doi request reprint Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome
    Dhiraj Tripathi
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Liver Int . 2016
    ..We studied the long-term outcomes of this approach...
  21. pmc U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients
    Dhiraj Tripathi
    Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
    Gut 64:1680-704. 2015
    ..They are not designed to deal with (1) the management of the underlying liver disease; (2) the management of variceal haemorrhage in children; or (3) variceal haemorrhage from other aetiological conditions. ..
  22. doi request reprint Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation
    Joanna A Leithead
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK NIHR Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham, UK
    Gut 64:1111-9. 2015
    ..Our aim was to determine whether NSBB use was a risk factor for mortality in patients with end-stage chronic liver disease and ascites awaiting liver transplantation...
  23. doi request reprint Liver in cardiopulmonary disease
    Naveen Polavarapu
    Liver Unit, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2TH, UK
    Best Pract Res Clin Gastroenterol 27:497-512. 2013
    ..There is no effective therapy and outcomes after liver transplantation are variable. ..
  24. doi request reprint An update on the diagnosis and management of Budd-Chiari syndrome
    Ross MacNicholas
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Expert Rev Gastroenterol Hepatol 6:731-44. 2012
    ..The diagnosis, initial management and long-term follow-up of patients with Budd-Chiari syndrome is reviewed. The concept of individualization of treatment and a stepwise approach to invasive procedures is also discussed...
  25. doi request reprint Beta-blockers in portal hypertension: new developments and controversies
    Dhiraj Tripathi
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Liver Int 34:655-67. 2014
    ..Beta-blockers have been shown to reduce bacterial translocation and spontaneous bacterial peritonitis in cirrhosis. ..